[Effectiveness and safety of 150 mg vs 300 mg ranitidine twice a day in duodenal ulcer]. 1993

M Schraier, and A Jorge, and J C Pereyra, and J Carri, and M Padua-Videla, and P Hoffenberg, and J Villalobos, and J Orillac, and M Waserstein, and S Mendoza

394 patients with endoscopically diagnosed duodenal ulcer were randomly allocated to treatment with ranitidine 150 bid o ranitidine 300 mg bid in a prospective double-blind multicenter trial conducted in seven LatinoAmerican countries. Endoscopy at 4 weeks showed complete ulcer healing en 171 of 196 patients (87.2%) treated with ranitidine 150 mg bid and 178 of 198 (89.9%) treated with ranitidine 300 mg bid. Both treatment regimens were equally effective at rapidly reducing the incidence of ulcer-related symptoms. It is possible that higher dosage regimen of ranitidine would be useful in patients with more severe duodenal ulcer disease.

UI MeSH Term Description Entries
D008297 Male Males
D008800 Mexico A country in NORTH AMERICA, bordering the Caribbean Sea and the Gulf of Mexico, between BELIZE and the UNITED STATES, and bordering the North Pacific Ocean, between Guatemala and the UNITED STATES.
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010176 Panama A country in CENTRAL AMERICA, bordering both the Caribbean Sea and the North Pacific Ocean, between COLOMBIA and COSTA RICA.
D011899 Ranitidine A non-imidazole blocker of those histamine receptors that mediate gastric secretion (H2 receptors). It is used to treat gastrointestinal ulcers. AH-19065,Biotidin,N (2-(((5-((Dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine,Ranisen,Ranitidin,Ranitidine Hydrochloride,Sostril,Zantac,Zantic,AH 19065,AH19065,Hydrochloride, Ranitidine
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004381 Duodenal Ulcer A PEPTIC ULCER located in the DUODENUM. Curling's Ulcer,Curling Ulcer,Curlings Ulcer,Duodenal Ulcers,Ulcer, Curling,Ulcer, Duodenal,Ulcers, Duodenal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M Schraier, and A Jorge, and J C Pereyra, and J Carri, and M Padua-Videla, and P Hoffenberg, and J Villalobos, and J Orillac, and M Waserstein, and S Mendoza
August 1984, Lancet (London, England),
M Schraier, and A Jorge, and J C Pereyra, and J Carri, and M Padua-Videla, and P Hoffenberg, and J Villalobos, and J Orillac, and M Waserstein, and S Mendoza
April 1988, The Journal of the Association of Physicians of India,
M Schraier, and A Jorge, and J C Pereyra, and J Carri, and M Padua-Videla, and P Hoffenberg, and J Villalobos, and J Orillac, and M Waserstein, and S Mendoza
September 1985, The American journal of gastroenterology,
M Schraier, and A Jorge, and J C Pereyra, and J Carri, and M Padua-Videla, and P Hoffenberg, and J Villalobos, and J Orillac, and M Waserstein, and S Mendoza
September 1986, Gut,
M Schraier, and A Jorge, and J C Pereyra, and J Carri, and M Padua-Videla, and P Hoffenberg, and J Villalobos, and J Orillac, and M Waserstein, and S Mendoza
July 1986, International journal of clinical pharmacology, therapy, and toxicology,
M Schraier, and A Jorge, and J C Pereyra, and J Carri, and M Padua-Videla, and P Hoffenberg, and J Villalobos, and J Orillac, and M Waserstein, and S Mendoza
June 1986, Journal of clinical gastroenterology,
M Schraier, and A Jorge, and J C Pereyra, and J Carri, and M Padua-Videla, and P Hoffenberg, and J Villalobos, and J Orillac, and M Waserstein, and S Mendoza
January 1989, Revista do Hospital das Clinicas,
M Schraier, and A Jorge, and J C Pereyra, and J Carri, and M Padua-Videla, and P Hoffenberg, and J Villalobos, and J Orillac, and M Waserstein, and S Mendoza
September 1986, Scandinavian journal of gastroenterology,
M Schraier, and A Jorge, and J C Pereyra, and J Carri, and M Padua-Videla, and P Hoffenberg, and J Villalobos, and J Orillac, and M Waserstein, and S Mendoza
June 1987, Alimentary pharmacology & therapeutics,
M Schraier, and A Jorge, and J C Pereyra, and J Carri, and M Padua-Videla, and P Hoffenberg, and J Villalobos, and J Orillac, and M Waserstein, and S Mendoza
June 1993, Minerva gastroenterologica e dietologica,
Copied contents to your clipboard!